ProfileGDS4718 / 228984_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 48% 51% 52% 56% 50% 52% 60% 49% 50% 51% 51% 53% 55% 51% 48% 52% 51% 57% 59% 55% 53% 48% 42% 49% 52% 46% 46% 49% 62% 54% 50% 55% 45% 57% 51% 55% 55% 54% 51% 52% 60% 52% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6184352
GSM549102patient 115, normal, homogenized [OPG study]5.4194948
GSM549104patient 119, normal, homogenized [OPG study]5.5617351
GSM549108patient 138, normal, homogenized [OPG study]5.6543452
GSM549119patient 077, normal, homogenized [OPG study]5.8782856
GSM549133patient 032, cancer, homogenized [OPG study]5.4363150
GSM549139patient 042, cancer, homogenized [OPG study]5.6068752
GSM549099patient 107, normal, homogenized [OPG study]6.0931260
GSM549109patient 139, normal, homogenized [OPG study]5.4590949
GSM549110patient 046, normal, homogenized [OPG study]5.487450
GSM549114patient 063, normal, homogenized [OPG study]5.5337651
GSM549122patient 082, normal, homogenized [OPG study]5.5536451
GSM549134patient 033, cancer, homogenized [OPG study]5.6858153
GSM549136patient 036, cancer, homogenized [OPG study]5.7373255
GSM549140patient 044, cancer, homogenized [OPG study]5.5142751
GSM549111patient 047, normal, homogenized [OPG study]5.3845948
GSM549113patient 057, normal, homogenized [OPG study]5.5596752
GSM549132patient 031, cancer, homogenized [OPG study]5.5407151
GSM549137patient 038, cancer, homogenized [OPG study]5.9241157
GSM549142patient 047, cancer, homogenized [OPG study]6.1450259
GSM549100patient 110, normal, homogenized [OPG study]5.8087255
GSM549107patient 135, normal, homogenized [OPG study]5.634753
GSM549115patient 068, normal, homogenized [OPG study]5.3616248
GSM549116patient 072, normal, homogenized [OPG study]5.0645742
GSM549120patient 078, normal, homogenized [OPG study]5.4376349
GSM549131patient 030, cancer, homogenized [OPG study]5.5744552
GSM549118patient 074, normal, homogenized [OPG study]5.3172446
GSM549129patient 027, cancer, homogenized [OPG study]5.3361546
GSM549123patient 088, normal, homogenized [OPG study]5.4490849
GSM549124patient 006, cancer, homogenized [OPG study]6.2788862
GSM549126patient 015, cancer, homogenized [OPG study]5.7513554
GSM549128patient 025, cancer, homogenized [OPG study]5.5292750
GSM549103patient 117, normal, homogenized [OPG study]5.8339755
GSM549117patient 073, normal, homogenized [OPG study]5.2246345
GSM549138patient 041, cancer, homogenized [OPG study]5.9399357
GSM549141patient 045, cancer, homogenized [OPG study]5.5581851
GSM549130patient 028, cancer, homogenized [OPG study]5.7955255
GSM549101patient 111, normal, homogenized [OPG study]5.8251955
GSM549105patient 128, normal, homogenized [OPG study]5.7500354
GSM549106patient 134, normal, homogenized [OPG study]5.5083751
GSM549112patient 048, normal, homogenized [OPG study]5.6081752
GSM549125patient 011, cancer, homogenized [OPG study]6.138460
GSM549127patient 024, cancer, homogenized [OPG study]5.6529352
GSM549135patient 035, cancer, homogenized [OPG study]6.2728762